APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Trial Imaging

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Clinical Trial Imaging Market Analysis and Forecast 2026-2032

5 June 2026190 pages

Choose your research edition.

Industry ResearchAI Clinical Trial Imaging Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Trial Imaging Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal AI Clinical Trial Imaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Trial Imaging Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Trial Imaging Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global AI Clinical Trial Imaging market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Clinical Trial Imaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Clinical Trial Imaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Clinical Trial Imaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Clinical Trial Imaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Clinical Trial Imaging include AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI and Quibim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Clinical Trial Imaging, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Clinical Trial Imaging, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Clinical Trial Imaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Clinical Trial Imaging revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Clinical Trial Imaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Clinical Trial Imaging revenue, projected growth trends, production technology, application and end-user industry.

AI Clinical Trial Imaging Segment by Company

AICure

Brainomix

Clario

Lantern Pharma

Median

Neuroute

Owkin

PathAI

Quibim

Saama

Spectral

VIDA

Voiant

AI Clinical Trial Imaging Segment by Type

Based on Machine Learning

Based on Deep Learning

Others

AI Clinical Trial Imaging Segment by Application

Telemedicine

Diagnostic Assistance

Clinical Decision Support

Others

AI Clinical Trial Imaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Imaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Clinical Trial Imaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Clinical Trial Imaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Clinical Trial Imaging revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Based on Machine Learning Major Player Table 3. Based on Deep Learning Major Player Table 4. Others Major Player Table 5. Global AI Clinical Trial Imaging Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Telemedicine Major Player Table 7. Diagnostic Assistance Major Player Table 8. Clinical Decision Support Major Player Table 9. Others Major Player Table 10. AI Clinical Trial Imaging Industry Trends Table 11. AI Clinical Trial Imaging Industry Drivers Table 12. AI Clinical Trial Imaging Industry Opportunities and Challenges Table 13. AI Clinical Trial Imaging Industry Restraints Table 14. Global AI Clinical Trial Imaging Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global AI Clinical Trial Imaging Market Size by Region (2021-2026) & (US$ Million) Table 16. Global AI Clinical Trial Imaging Market Share by Region (2021-2026) Table 17. Global AI Clinical Trial Imaging Market Size by Region (2027-2032) & (US$ Million) Table 18. Global AI Clinical Trial Imaging Market Share by Region (2027-2032) Table 19. Global AI Clinical Trial Imaging Revenue by Players (US$ Million) & (2021-2026) Table 20. Global AI Clinical Trial Imaging Revenue Market Share by Players (2021-2026) Table 21. Global AI Clinical Trial Imaging Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global AI Clinical Trial Imaging Key Players Headquarters & Area Served Table 23. Global AI Clinical Trial Imaging Players, Product Type & Application Table 24. Global AI Clinical Trial Imaging Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global AI Clinical Trial Imaging by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global AI Clinical Trial Imaging Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 29. Global AI Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 30. Global AI Clinical Trial Imaging Revenue Market Share by Type (2021-2026) Table 31. Global AI Clinical Trial Imaging Revenue Market Share by Type (2027-2032) Table 32. Global AI Clinical Trial Imaging Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 34. Global AI Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 35. Global AI Clinical Trial Imaging Revenue Market Share by Application (2021-2026) Table 36. Global AI Clinical Trial Imaging Revenue Market Share by Application (2027-2032) Table 37. AICure Company Information Table 38. AICure Business Overview Table 39. AICure AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AICure AI Clinical Trial Imaging Product Portfolio Table 41. AICure Recent Development Table 42. Brainomix Company Information Table 43. Brainomix Business Overview Table 44. Brainomix AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Brainomix AI Clinical Trial Imaging Product Portfolio Table 46. Brainomix Recent Development Table 47. Clario Company Information Table 48. Clario Business Overview Table 49. Clario AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Clario AI Clinical Trial Imaging Product Portfolio Table 51. Clario Recent Development Table 52. Lantern Pharma Company Information Table 53. Lantern Pharma Business Overview Table 54. Lantern Pharma AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Lantern Pharma AI Clinical Trial Imaging Product Portfolio Table 56. Lantern Pharma Recent Development Table 57. Median Company Information Table 58. Median Business Overview Table 59. Median AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Median AI Clinical Trial Imaging Product Portfolio Table 61. Median Recent Development Table 62. Neuroute Company Information Table 63. Neuroute Business Overview Table 64. Neuroute AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Neuroute AI Clinical Trial Imaging Product Portfolio Table 66. Neuroute Recent Development Table 67. Owkin Company Information Table 68. Owkin Business Overview Table 69. Owkin AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Owkin AI Clinical Trial Imaging Product Portfolio Table 71. Owkin Recent Development Table 72. PathAI Company Information Table 73. PathAI Business Overview Table 74. PathAI AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. PathAI AI Clinical Trial Imaging Product Portfolio Table 76. PathAI Recent Development Table 77. Quibim Company Information Table 78. Quibim Business Overview Table 79. Quibim AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Quibim AI Clinical Trial Imaging Product Portfolio Table 81. Quibim Recent Development Table 82. Saama Company Information Table 83. Saama Business Overview Table 84. Saama AI Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Saama AI Clinical Trial Imaging Product Portfolio Table 86. Saama Recent Development Table 87. Spectral Company Information Table 88. Spectral Business Overview Table 89. Spectral AI Clinical Trial Imaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Spectral AI Clinical Trial Imaging Product Portfolio Table 91. Spectral Recent Development Table 92. VIDA Company Information Table 93. VIDA Business Overview Table 94. VIDA AI Clinical Trial Imaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. VIDA AI Clinical Trial Imaging Product Portfolio Table 96. VIDA Recent Development Table 97. Voiant Company Information Table 98. Voiant Business Overview Table 99. Voiant AI Clinical Trial Imaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Voiant AI Clinical Trial Imaging Product Portfolio Table 101. Voiant Recent Development Table 102. North America AI Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 103. North America AI Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 104. North America AI Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 105. North America AI Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 106. North America AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America AI Clinical Trial Imaging Revenue by Country (2021-2026) & (US$ Million) Table 108. North America AI Clinical Trial Imaging Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe AI Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe AI Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe AI Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe AI Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe AI Clinical Trial Imaging Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe AI Clinical Trial Imaging Revenue by Country (US$ Million) & (2027-2032) Table 116. China AI Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 117. China AI Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 118. China AI Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 119. China AI Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia AI Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia AI Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia AI Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia AI Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia AI Clinical Trial Imaging Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia AI Clinical Trial Imaging Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia AI Clinical Trial Imaging Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA AI Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA AI Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA AI Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA AI Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA AI Clinical Trial Imaging Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA AI Clinical Trial Imaging Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. AI Clinical Trial Imaging Image Figure 2. Global AI Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Clinical Trial Imaging Market Size Share 2021 VS 2025 VS 2032 Figure 4. Based on Machine Learning Image Figure 5. Based on Deep Learning Image Figure 6. Others Image Figure 7. Global AI Clinical Trial Imaging Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global AI Clinical Trial Imaging Market Size Share 2021 VS 2025 VS 2032 Figure 9. Telemedicine Image Figure 10. Diagnostic Assistance Image Figure 11. Clinical Decision Support Image Figure 12. Others Image Figure 13. Global AI Clinical Trial Imaging Market Size (US$ Million) & (2021-2032) Figure 14. Global AI Clinical Trial Imaging Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global AI Clinical Trial Imaging Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global AI Clinical Trial Imaging Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI Clinical Trial Imaging Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI Clinical Trial Imaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global AI Clinical Trial Imaging Revenue Market Share by Type (2021-2032) Figure 21. Global AI Clinical Trial Imaging Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Clinical Trial Imaging Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global AI Clinical Trial Imaging Revenue Market Share by Application (2021-2032) Figure 24. North America AI Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America AI Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 26. North America AI Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 27. North America AI Clinical Trial Imaging Revenue Share by Country (2021-2032) Figure 28. United States AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe AI Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe AI Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 33. Europe AI Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 34. Europe AI Clinical Trial Imaging Revenue Share by Country (2021-2032) Figure 35. Germany AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China AI Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China AI Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 45. China AI Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 46. Asia AI Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia AI Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 48. Asia AI Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 49. Asia AI Clinical Trial Imaging Revenue Share by Region (2021-2032) Figure 50. Japan AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA AI Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA AI Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 58. SAMEA AI Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 59. SAMEA AI Clinical Trial Imaging Revenue Share by Country (2021-2032) Figure 60. Brazil AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt AI Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Based on Machine Learning
  • Based on Deep Learning
  • Others
Applications
  • Telemedicine
  • Diagnostic Assistance
  • Clinical Decision Support
  • Others
Companies covered
  • AICure
  • Brainomix
  • Clario
  • Lantern Pharma
  • Median
  • Neuroute
  • Owkin
  • PathAI
  • Quibim
  • Saama
  • Spectral
  • VIDA
  • Voiant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Clinical Trial Imaging Market by Type
  3. 1.2.1 Global AI Clinical Trial Imaging Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Based on Machine Learning
  5. 1.2.3 Based on Deep Learning
  6. 1.2.4 Others
  7. 1.3 AI Clinical Trial Imaging Market by Application
  8. 1.3.1 Global AI Clinical Trial Imaging Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Telemedicine
  10. 1.3.3 Diagnostic Assistance
  11. 1.3.4 Clinical Decision Support
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 AI Clinical Trial Imaging Market Dynamics
  1. 2.1 AI Clinical Trial Imaging Industry Trends
  2. 2.2 AI Clinical Trial Imaging Industry Drivers
  3. 2.3 AI Clinical Trial Imaging Industry Opportunities and Challenges
  4. 2.4 AI Clinical Trial Imaging Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Clinical Trial Imaging Market Perspective (2021-2032)
  2. 3.2 Global AI Clinical Trial Imaging Growth Trends by Region
  3. 3.2.1 Global AI Clinical Trial Imaging Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Clinical Trial Imaging Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Clinical Trial Imaging Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Clinical Trial Imaging Revenue by Players
  2. 4.1.1 Global AI Clinical Trial Imaging Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Clinical Trial Imaging Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Clinical Trial Imaging Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Clinical Trial Imaging Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Clinical Trial Imaging Key Players Headquarters & Area Served
  7. 4.4 Global AI Clinical Trial Imaging Players, Product Type & Application
  8. 4.5 Global AI Clinical Trial Imaging Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Clinical Trial Imaging Market CR5 and HHI
  11. 4.6.3 2025 AI Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
5 AI Clinical Trial Imaging Market Size by Type
  1. 5.1 Global AI Clinical Trial Imaging Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 5.3 Global AI Clinical Trial Imaging Revenue Market Share by Type (2021-2032)
6 AI Clinical Trial Imaging Market Size by Application
  1. 6.1 Global AI Clinical Trial Imaging Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Clinical Trial Imaging Revenue by Application (2021-2032)
  3. 6.3 Global AI Clinical Trial Imaging Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AICure
  2. 7.1.1 AICure Company Information
  3. 7.1.2 AICure Business Overview
  4. 7.1.3 AICure AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AICure AI Clinical Trial Imaging Product Portfolio
  6. 7.1.5 AICure Recent Developments
  7. 7.2 Brainomix
  8. 7.2.1 Brainomix Company Information
  9. 7.2.2 Brainomix Business Overview
  10. 7.2.3 Brainomix AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Brainomix AI Clinical Trial Imaging Product Portfolio
  12. 7.2.5 Brainomix Recent Developments
  13. 7.3 Clario
  14. 7.3.1 Clario Company Information
  15. 7.3.2 Clario Business Overview
  16. 7.3.3 Clario AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Clario AI Clinical Trial Imaging Product Portfolio
  18. 7.3.5 Clario Recent Developments
  19. 7.4 Lantern Pharma
  20. 7.4.1 Lantern Pharma Company Information
  21. 7.4.2 Lantern Pharma Business Overview
  22. 7.4.3 Lantern Pharma AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lantern Pharma AI Clinical Trial Imaging Product Portfolio
  24. 7.4.5 Lantern Pharma Recent Developments
  25. 7.5 Median
  26. 7.5.1 Median Company Information
  27. 7.5.2 Median Business Overview
  28. 7.5.3 Median AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Median AI Clinical Trial Imaging Product Portfolio
  30. 7.5.5 Median Recent Developments
  31. 7.6 Neuroute
  32. 7.6.1 Neuroute Company Information
  33. 7.6.2 Neuroute Business Overview
  34. 7.6.3 Neuroute AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Neuroute AI Clinical Trial Imaging Product Portfolio
  36. 7.6.5 Neuroute Recent Developments
  37. 7.7 Owkin
  38. 7.7.1 Owkin Company Information
  39. 7.7.2 Owkin Business Overview
  40. 7.7.3 Owkin AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Owkin AI Clinical Trial Imaging Product Portfolio
  42. 7.7.5 Owkin Recent Developments
  43. 7.8 PathAI
  44. 7.8.1 PathAI Company Information
  45. 7.8.2 PathAI Business Overview
  46. 7.8.3 PathAI AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  47. 7.8.4 PathAI AI Clinical Trial Imaging Product Portfolio
  48. 7.8.5 PathAI Recent Developments
  49. 7.9 Quibim
  50. 7.9.1 Quibim Company Information
  51. 7.9.2 Quibim Business Overview
  52. 7.9.3 Quibim AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Quibim AI Clinical Trial Imaging Product Portfolio
  54. 7.9.5 Quibim Recent Developments
  55. 7.10 Saama
  56. 7.10.1 Saama Company Information
  57. 7.10.2 Saama Business Overview
  58. 7.10.3 Saama AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Saama AI Clinical Trial Imaging Product Portfolio
  60. 7.10.5 Saama Recent Developments
  61. 7.11 Spectral
  62. 7.11.1 Spectral Company Information
  63. 7.11.2 Spectral Business Overview
  64. 7.11.3 Spectral AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Spectral AI Clinical Trial Imaging Product Portfolio
  66. 7.11.5 Spectral Recent Developments
  67. 7.12 VIDA
  68. 7.12.1 VIDA Company Information
  69. 7.12.2 VIDA Business Overview
  70. 7.12.3 VIDA AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  71. 7.12.4 VIDA AI Clinical Trial Imaging Product Portfolio
  72. 7.12.5 VIDA Recent Developments
  73. 7.13 Voiant
  74. 7.13.1 Voiant Company Information
  75. 7.13.2 Voiant Business Overview
  76. 7.13.3 Voiant AI Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Voiant AI Clinical Trial Imaging Product Portfolio
  78. 7.13.5 Voiant Recent Developments
8 North America
  1. 8.1 North America AI Clinical Trial Imaging Revenue (2021-2032)
  2. 8.2 North America AI Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 8.3 North America AI Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 8.5 North America AI Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Clinical Trial Imaging Revenue by Country
  11. 8.6.1 North America AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Clinical Trial Imaging Revenue (2021-2032)
  2. 9.2 Europe AI Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 9.3 Europe AI Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 9.5 Europe AI Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Clinical Trial Imaging Revenue by Country
  11. 9.6.1 Europe AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Clinical Trial Imaging Revenue (2021-2032)
  2. 10.2 China AI Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 10.2.1 China AI Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 10.2.2 China AI Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 10.3 China AI Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 10.4 China AI Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 10.4.1 China AI Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 10.4.2 China AI Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 10.5 China AI Clinical Trial Imaging Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Clinical Trial Imaging Revenue (2021-2032)
  2. 11.2 Asia AI Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 11.3 Asia AI Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 11.5 Asia AI Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Clinical Trial Imaging Revenue by Country
  11. 11.6.1 Asia AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Clinical Trial Imaging Revenue (2021-2032)
  2. 12.2 SAMEA AI Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Clinical Trial Imaging Revenue by Country
  11. 12.6.1 SAMEA AI Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst